search
Back to results

Virtual Reality Analgesia for Brief Thermal Pain

Primary Purpose

Pain, Acute

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
virtual reality game
Sponsored by
University of Washington
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Pain, Acute focused on measuring Pain control

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Currently enrolled in a course at the University of Washington Psychology Dept., participating in the UW Psychology subject pool
  • Able to read, write and comprehend English
  • Able to complete study measures
  • Willing to follow our UW approved instructions
  • 18 years of age or older
  • Currently enrolled in a course at the University of Washington Psychology Dept., participating in the UW Psychology subject pool
  • Able to read, write and comprehend English
  • Able to complete study measures
  • Willing to follow our UW approved instructions
  • 18 years of age or older The following temporary inclusion/exclusion criterion will exist only as long as required or appropriate for COVID pandemic conditions.

COVID-19 precautions. Vaccinated: Individuals are considered fully vaccinated 2 weeks after the second dose in a 2-dose series (e.g., Pfizer or Moderna) or 2 weeks after a single-dose vaccine (e.g., Johnson & Johnson).

All students and researchers must wear masks at all times during the study, and participants and researchers must provide proof of full vaccination for full participation.

If participants do not have proof of vaccination or are unvaccinated, they are still free to sign up for the study. They are invited. They can still earn the extra credit by reading educational materials, in person, during their scheduled time slot. If unvaccinated, or if they have no proof of vaccination, we request that students provide proof of a negative COVID-19 test from the UW test site at the faculty lounge, dated within 24 hours of the study (non-vaccinated students need a recent negative COVID-19 test from the UW before participating in the non-VR educational materials option.

-

Exclusion Criteria:

  • People how have already previously participated in this same study (e.g., last quarter) are not eligible to participate again.
  • Not enrolled in a course at the University of Washington Psychology Dept., participating in the UW Psychology subject pool
  • Not be able to read, write and comprehend English
  • Younger than 18 years of age.
  • Not capable of completing measures
  • Not capable of indicating pain intensity,
  • Not capable of filling out study measures,
  • Extreme susceptibility to motion sickness,
  • Seizure history,
  • Unusual sensitivity or lack of sensitivity to pain,
  • Sensitive skin,
  • Sensitive feet
  • Migraines
  • Diabetes

The following temporary inclusion/exclusion criterion will exist only as long as required or appropriate for COVID pandemic conditions.

COVID-19 precautions. Vaccinated: Individuals are considered fully vaccinated 2 weeks after the second dose in a 2-dose series (e.g., Pfizer or Moderna) or 2 weeks after a single-dose vaccine (e.g., Johnson & Johnson).

All students and researchers must wear masks at all times during the study, and participants and researchers must provide proof of full vaccination for full participation.

If participants do not have proof of vaccination or are unvaccinated, they are still free to sign up for the study. They are invited. They can still earn the extra credit by reading educational materials, in person, during their scheduled time slot. If unvaccinated, or if they have no proof of vaccination, we request that students provide proof of a negative COVID-19 test from the UW test site at the faculty lounge, dated within 24 hours of the study.

Sites / Locations

  • University of Washington (only Psych students eligible, public not eligible for participation)

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Treatment Order 1

Treatment Order 2

Arm Description

Treatment order 1: Low Tech (less interactive) Virtual Reality for 1st pain stimulus+ High Tech for 2nd pain stimulus

Treatment order 2: High Tech VR (more interactive) for 1st pain stimulus + Low Tech for 2nd pain stimulus.

Outcomes

Primary Outcome Measures

Worst pain, baseline, participant's rating of "worst pain" during baseline measure
Baseline, Worst pain rating using a single graphic rating scale, 0 = no pain, 10 = excruciating pain
participant's rating of "worst pain" during test phase
Test phase, Worst pain rating using a single graphic rating scale, 0 = no pain, 10 = excruciating pain

Secondary Outcome Measures

Baseline, participants rating of "time spent thinking about pain"
Baseline Time thinking, Single a single graphic rating scale, 0 = none of the time, 10 = all of the time
Test Phase, participants rating of "time spent thinking about pain" during test phase
Test phase, Time rating, using a single graphic rating scale, 0 = none of the time, 10 = all of the time
Baseline, participants rating of "pain unpleasantness"
Baseline, Unpleasant rating, using single graphic rating scale, 0 = not unpleasant at all, 10 = excruciatingly unpleasant
Test phase, participants rating of "pain unpleasantness" during test phase
Test phase, pain unpleasantness, 0 = not unpleasant at all, 10 = excruciatingly unpleasant
Baseline, participants rating of "Fun" during baseline
Baseline fun, 0 = no fun at all, 10 = extremely fun
Test Phase, participants ratings of "Fun" during test phase
Test phase fun, 0 = no fun at all, 10 = extremely fun
Baseline pain intensity: participants ratings of pain intensity during brief pair of 10 sec stimuli
Baseline, pain intensity rating using a single graphic rating scale, 0 = no pain, 10 = excruciating pain
Accuracy on the odd number task during No VR, Low tech VR and High tech VR
participants accuracy on the attention demanding "odd number" task (Hoffman, 2021)

Full Information

First Posted
November 1, 2021
Last Updated
August 19, 2022
Sponsor
University of Washington
search

1. Study Identification

Unique Protocol Identification Number
NCT05130307
Brief Title
Virtual Reality Analgesia for Brief Thermal Pain
Official Title
Virtual Reality Analgesia for Brief Thermal Pain
Study Type
Interventional

2. Study Status

Record Verification Date
August 2022
Overall Recruitment Status
Completed
Study Start Date
April 25, 2022 (Actual)
Primary Completion Date
June 3, 2022 (Actual)
Study Completion Date
June 3, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Washington

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Using immersive virtual reality as a form of pain distraction during a brief "painful but tolerable" temperature.
Detailed Description
This study will use Quantitative Sensory Testing (computer-controlled brief 10 second thermal pain stimuli) in healthy college students. The primary aim is to conduct a randomized, controlled study with healthy volunteers to explore whether interacting with virtual objects in VR via a highly immersive VR system makes VR significantly more effective/powerful compared to a less immersive VR system, vs. No VR, for reducing pain during quantitative sensory testing.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Acute
Keywords
Pain control

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
A Mixed Model repeated measures ANOVA or non-parametric tests if appropriate will be conducted on worst pain ratings. Within subjects crossover design, VR treatment order randomized (some participants receive order 1 Low Tech VR + High Tech VR = Arm 1, some participants receive order 2 High Tech VR + Low Tech VR) = Arm 2. . Treatment order 1: Low Tech/less interactive Virtual Reality for 1st brief pain stimulus+ washout period + High Tech for 2nd brief pain stimulus. Treatment order 2: High Tech/more interactive VR for 1st brief pain stimulus + washout period + Low Tech for 2nd brief pain stimulus (Arm 2)..
Masking
Participant
Masking Description
Although no deception is involved, participants who receive VR will remain unaware of the immersiveness of the VR systems they are receiving.
Allocation
Randomized
Enrollment
48 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Treatment Order 1
Arm Type
Experimental
Arm Description
Treatment order 1: Low Tech (less interactive) Virtual Reality for 1st pain stimulus+ High Tech for 2nd pain stimulus
Arm Title
Treatment Order 2
Arm Type
Active Comparator
Arm Description
Treatment order 2: High Tech VR (more interactive) for 1st pain stimulus + Low Tech for 2nd pain stimulus.
Intervention Type
Behavioral
Intervention Name(s)
virtual reality game
Intervention Description
participants interact with a computer generated world
Primary Outcome Measure Information:
Title
Worst pain, baseline, participant's rating of "worst pain" during baseline measure
Description
Baseline, Worst pain rating using a single graphic rating scale, 0 = no pain, 10 = excruciating pain
Time Frame
Immediately after a single 10 second test (no more than 10 minutes before the subsequent test stiim)
Title
participant's rating of "worst pain" during test phase
Description
Test phase, Worst pain rating using a single graphic rating scale, 0 = no pain, 10 = excruciating pain
Time Frame
Immediately after each single 10 second test stimulus (< 10 minutes after baseline pain rating)
Secondary Outcome Measure Information:
Title
Baseline, participants rating of "time spent thinking about pain"
Description
Baseline Time thinking, Single a single graphic rating scale, 0 = none of the time, 10 = all of the time
Time Frame
Immediately after a single 10 second test (no more than 10 minutes before the subsequent test stiim)
Title
Test Phase, participants rating of "time spent thinking about pain" during test phase
Description
Test phase, Time rating, using a single graphic rating scale, 0 = none of the time, 10 = all of the time
Time Frame
Immediately after each single 10 second test stimulus (< 10 minutes after baseline pain rating)
Title
Baseline, participants rating of "pain unpleasantness"
Description
Baseline, Unpleasant rating, using single graphic rating scale, 0 = not unpleasant at all, 10 = excruciatingly unpleasant
Time Frame
Immediately after a single 10 second test (no more than 10 minutes before the subsequent test stiim)
Title
Test phase, participants rating of "pain unpleasantness" during test phase
Description
Test phase, pain unpleasantness, 0 = not unpleasant at all, 10 = excruciatingly unpleasant
Time Frame
Immediately after each single 10 second test stimulus (< 10 minutes after baseline pain rating)
Title
Baseline, participants rating of "Fun" during baseline
Description
Baseline fun, 0 = no fun at all, 10 = extremely fun
Time Frame
Immediately after a single 10 second test (no more than 10 minutes before the subsequent test stiim)
Title
Test Phase, participants ratings of "Fun" during test phase
Description
Test phase fun, 0 = no fun at all, 10 = extremely fun
Time Frame
Immediately after each single 10 second test stimulus (< 10 minutes after baseline fun rating)
Title
Baseline pain intensity: participants ratings of pain intensity during brief pair of 10 sec stimuli
Description
Baseline, pain intensity rating using a single graphic rating scale, 0 = no pain, 10 = excruciating pain
Time Frame
Immediately after a single 10 second test (no more than 10 minutes before the subsequent test stiim)
Title
Accuracy on the odd number task during No VR, Low tech VR and High tech VR
Description
participants accuracy on the attention demanding "odd number" task (Hoffman, 2021)
Time Frame
No pain during this measure, measured within 10 minutes after the QST measures are completed.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Currently enrolled in a course at the University of Washington Psychology Dept., participating in the UW Psychology subject pool Able to read, write and comprehend English Able to complete study measures Willing to follow our UW approved instructions 18 years of age or older Currently enrolled in a course at the University of Washington Psychology Dept., participating in the UW Psychology subject pool Able to read, write and comprehend English Able to complete study measures Willing to follow our UW approved instructions 18 years of age or older The following temporary inclusion/exclusion criterion will exist only as long as required or appropriate for COVID pandemic conditions. COVID-19 precautions. Vaccinated: Individuals are considered fully vaccinated 2 weeks after the second dose in a 2-dose series (e.g., Pfizer or Moderna) or 2 weeks after a single-dose vaccine (e.g., Johnson & Johnson). All students and researchers must wear masks at all times during the study, and participants and researchers must provide proof of full vaccination for full participation. If participants do not have proof of vaccination or are unvaccinated, they are still free to sign up for the study. They are invited. They can still earn the extra credit by reading educational materials, in person, during their scheduled time slot. If unvaccinated, or if they have no proof of vaccination, we request that students provide proof of a negative COVID-19 test from the UW test site at the faculty lounge, dated within 24 hours of the study (non-vaccinated students need a recent negative COVID-19 test from the UW before participating in the non-VR educational materials option. - Exclusion Criteria: People how have already previously participated in this same study (e.g., last quarter) are not eligible to participate again. Not enrolled in a course at the University of Washington Psychology Dept., participating in the UW Psychology subject pool Not be able to read, write and comprehend English Younger than 18 years of age. Not capable of completing measures Not capable of indicating pain intensity, Not capable of filling out study measures, Extreme susceptibility to motion sickness, Seizure history, Unusual sensitivity or lack of sensitivity to pain, Sensitive skin, Sensitive feet Migraines Diabetes The following temporary inclusion/exclusion criterion will exist only as long as required or appropriate for COVID pandemic conditions. COVID-19 precautions. Vaccinated: Individuals are considered fully vaccinated 2 weeks after the second dose in a 2-dose series (e.g., Pfizer or Moderna) or 2 weeks after a single-dose vaccine (e.g., Johnson & Johnson). All students and researchers must wear masks at all times during the study, and participants and researchers must provide proof of full vaccination for full participation. If participants do not have proof of vaccination or are unvaccinated, they are still free to sign up for the study. They are invited. They can still earn the extra credit by reading educational materials, in person, during their scheduled time slot. If unvaccinated, or if they have no proof of vaccination, we request that students provide proof of a negative COVID-19 test from the UW test site at the faculty lounge, dated within 24 hours of the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hunter Hoffman, M.S., Ph.D.
Organizational Affiliation
University of Washington
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Washington (only Psych students eligible, public not eligible for participation)
City
Seattle
State/Province
Washington
ZIP/Postal Code
98195
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Aggregated data will be provided upon request on a case by case basis (e.g., for meta-analyses).
IPD Sharing Time Frame
any time after publication
IPD Sharing Access Criteria
meta-analysis
Citations:
PubMed Identifier
32038200
Citation
Al-Ghamdi NA, Meyer WJ 3rd, Atzori B, Alhalabi W, Seibel CC, Ullman D, Hoffman HG. Virtual Reality Analgesia With Interactive Eye Tracking During Brief Thermal Pain Stimuli: A Randomized Controlled Trial (Crossover Design). Front Hum Neurosci. 2020 Jan 23;13:467. doi: 10.3389/fnhum.2019.00467. eCollection 2019.
Results Reference
background
PubMed Identifier
34021173
Citation
Hoffman HG. Interacting with virtual objects via embodied avatar hands reduces pain intensity and diverts attention. Sci Rep. 2021 May 21;11(1):10672. doi: 10.1038/s41598-021-89526-4.
Results Reference
background

Learn more about this trial

Virtual Reality Analgesia for Brief Thermal Pain

We'll reach out to this number within 24 hrs